Couldn't agree more with your reason to buy. If I may add, Profound Medical is not only an unknown, it is a company on the rise. Furthermore, unknowns are hard to find at this point in their progression. Unkowns are often found during phase 2 or phase 3 trials with no revenue, no analyst coverage, and a lot of questions in timing. Profound, being a Canadian company trading on the Toronto Stock exchange, and then having a dual listing as OTC kept them a relative unkown throughout the trials phase. These guys just got uplisted to NASDAQ, are at commercialization, have buy rating from analysts including Raymond James, and are still unkown. They have already sold units abroad and are beginning sales domestically. We don't have to wait for more trials for revenue. I do think there is a little more time to buy, but not much. This uplisting to NASDAQ opens the doors. I really think we can fly in 2020 and beyond. All just my opinions. Good luck everyone!
News 
Market Data 
Discover 
